Editas Medicine (EDIT) Assets Average (2016 - 2025)

Editas Medicine (EDIT) has 10 years of Assets Average data on file, last reported at $194.1 million in Q4 2025.

• On a quarterly basis, Assets Average fell 41.97% year-over-year to $194.1 million in Q4 2025; TTM through Dec 2025 was $194.1 million, a 41.97% decrease from a year earlier, with the FY2025 full-year figure at $264.1 million, down 37.18% from the prior year.
• Assets Average for Q4 2025 stood at $194.1 million, down from $206.2 million in the prior quarter.
• Over the last five years, Assets Average for EDIT reached as high as $768.1 million in Q2 2021 and fell as low as $194.1 million in Q4 2025.
• Historically, Assets Average has averaged $487.0 million across 5 years, with a median of $502.5 million in 2023.
• Across the five-year window, Assets Average surged 38.67% in 2021 and slumped 42.53% in 2025, its largest moves.
• Year by year, Assets Average stood at $697.3 million in 2021, then decreased by 25.04% to $522.7 million in 2022, then retreated by 3.97% to $501.9 million in 2023, then slumped by 33.34% to $334.6 million in 2024, then tumbled by 41.97% to $194.1 million in 2025.
• Per Business Quant data, the three most recent Assets Average figures were $194.1 million in Q4 2025, $206.2 million in Q3 2025, and $237.1 million in Q2 2025.